Progress in gene targeting: Using mutant mice to study renal function and disease

Kidney International

Volumn 74, Issue 4, 2008, Pages 427-437

  Kohan, Donald E ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

Cre recombinase; Kidney; Knockout; loxP; Transgenic

Indexed keywords

CRE RECOMBINASE; DOXYCYCLINE; TAMOXIFEN; TETRACYCLINE;

CELL TYPE; GENE EXPRESSION; GENE MUTATION; GENE TARGETING; GENETIC REGULATION; IN VIVO STUDY; KIDNEY DISEASE; KIDNEY FUNCTION; MUTANT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RNA INTERFERENCE; TRANSGENIC MOUSE;

EID: 48649101525     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.146     Document Type: Review

References (92)

1. Feil R. Conditional somatic mutagenesis in the mouse using site-specific recombinases. Handb Exp Pharmacol 2007; 178: 3-28.
2. Sternberg N, Hamilton D. Bacteriophage P1 site-specific recombination. I. Recombination between loxP sites. J Mol Biol 1981; 150: 467-486.
3. Dworniczak B, Skryabin B, Tchinda J et al. Inducible Cre/loxP recombination in the mouse proximal tubule. Nephron Exp Nephrol 2007; 106: e11-e20.
4. Iwano M, Plieth D, Danoff TM et al. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 2002; 110: 341-350.
5. Rubera I, Poujeol C, Bertin G et al. Specific Cre/Lox recombination in the mouse proximal tubule. J Am Soc Nephrol 2004; 15: 2050-2056.
6. Higgins DF, Kimura K, Bernhardt WM et al. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest 2007; 117: 3810-3820.
7. Rankin EB, Tomaszewski JE, Haase VH. Renal cyst development in mice with conditional inactivation of the von Hippel-Lindau tumor suppressor. Cancer Res 2006; 66: 2576-2583.
8. Ding Y, Davisson R, Hardy D et al. The kidney androgen-regulated protein promoter confers renal proximal tubule cell-specific and highly androgen-responsive expression on the human angiotensinogen gene in transgenic mice. J Biol Chem 1997; 272: 28142-28148.
9. Stricklett PK, Taylor D, Nelson RD et al. Thick ascending limb-specific expression of Cre recombinase. Am J Physiol Renal Physiol 2003; 285: F33-F39.
10. Ahn D, Ge Y, Stricklett PK et al. Collecting duct-specific knockout of endothelin-1 causes hypertension and sodium retention. J Clin Invest 2004; 114: 504-511.
11. Guan Y, Hao C, Cha DR et al. Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption. Nat Med 2005; 11: 861-866.
12. Zhang H, Zhang A, Kohan DE et al. Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedione-induced fluid retention. Proc Natl Acad Sci USA 2005; 102: 9406-9411.
13. Ge Y, Bagnall A, Stricklett PK et al. Collecting duct-specific knockout of the endothelin B receptor causes hypertension and sodium retention. Am J Physiol Renal Physiol 2006; 291: F1274-F1280.
14. Ge Y, Stricklett PK, Hughes AK et al. Collecting duct-specific knockout of the endothelin A receptor alters renal vasopressin responsiveness, but not sodium excretion or blood pressure. Am J Physiol Renal Physiol 2005; 289: F692-F698.
15. Ronzaud C, Loffing J, Bleich M et al. Impairment of sodium balance in mice deficient in renal principal cell mineralocorticoid receptor. J Am Soc Nephrol 2007; 18: 1679-1687.
16. Miller RL, Zhang P, Smith M et al. V-ATPase B1-subunit promoter drives expression of EGFP in intercalated cells of kidney, clear cells of epididymis and airway cells of lung in transgenic mice. Am J Physiol Cell Physiol 2005; 288: C1134-C1144.
17. Rojek A, Fuchtbauer EM, Kwon TH et al. Severe urinary concentrating defect in renal collecting duct-selective AQP2 conditional-knockout mice. Proc Natl Acad Sci USA 2006; 103: 6037-6042.
18. Rubera I, Loffing J, Palmer L et al. Collecting duct-specific gene inactivation of alpha ENaC in the mouse kidney does not impair sodium and potassium balance. J Clin Invest 2003; 112: 554-565.
19. Lin F, Hiesberger T, Cordes K et al. Kidney-specific inactivation of the KIF3A subunit of kinesin-II inhibits renal ciliogenesis and produces polycystic kidney disease. Proc Natl Acad Sci USA 2003; 100: 5286-5291.
20. Lantinga-van Leeuwen IS, Leonhard WN, van de Wal A et al. Transgenic mice expressing tamoxifen-inducible Cre for somatic gene modification in renal epithelial cells. Genesis 2006; 44: 225-232.
21. Shao X, Somlo S, Igarashi P. Epithelial-specific Cre/lox recombination in the developing kidney and genitourinary tract. J Am Soc Nephrol 2002; 13: 1837-1846.
22. Traykova M, Jennemann R, Sandhoff R et al. Generation of inducible renal tubule-specific comprehensive gene deficiency in the mouse. J Am Soc Nephrol 2007; 17: 334A.
23. Bouchard M, Souabni A, Busslinger M. Tissue-specific expression of cre recombinase from the Pax8 locus. Genesis 2004; 38: 105-109.
24. Ohyama T, Groves AK. Generation of Pax2-Cre mice by modification of a Pax2 bacterial artificial chromosome. Genesis 2004; 38: 195-199.
25. Naray-Fejes-Toth A, Fejes-Toth G. Novel mouse strain with Cre recombinase in 11beta-hydroxysteroid dehydrogenase-2-expressing cells. Am J Physiol Renal Physiol 2007; 292: F486-F494.
26. Chen L, Kim SM, Oppermann M et al. Regulation of renin in mice with Cre recombinase-mediated deletion of G protein Gsalpha in juxtaglomerular cells. Am J Physiol Renal Physiol 2007; 292: F27-F37.
27. Eremina V, Sood M, Haigh J et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 2003; 111: 707-716.
28. Juhila J, Roozendaal R, Lassila M et al. Podocyte cell-specific expression of doxycycline inducible Cre recombinase in mice. J Am Soc Nephrol 2006; 17: 648-654.
29. Moeller MJ, Sanden SK, Soofi A et al. Podocyte-specific expression of cre recombinase in transgenic mice. Genesis 2003; 35: 39-42.
30. Aufderheide E, Chiquet-Ehrismann R, Ekblom P. Epithelial-mesenchymal interactions in the developing kidney lead to expression of tenascin in the mesenchyme. J Cell Biol 1987; 105: 599-608.
31. Leheste JR, Melsen F, Wellner M et al. Hypocalcemia and osteopathy in mice with kidney-specific megalin gene defect. FASEB J 2003; 17: 247-249.
32. Piontek KB, Huso DL, Grinberg A et al. A functional floxed allele of Pkd1 that can be conditionally inactivated in vivo. J Am Soc Nephrol 2004; 15: 3035-3043.
33. Sansom OJ, Griffiths DF, Reed KR et al. Apc deficiency predisposes to renal carcinoma in the mouse. Oncogene 2005; 24: 8205-8210.
34. Oxburgh L, Chu GC, Michael SK et al. TGFbeta superfamily signals are required for morphogenesis of the kidney mesenchyme progenitor population. Development 2004; 131: 4593-4605.
35. Lan Y, Wang Q, Ovitt CE et al. A unique mouse strain expressing Cre recombinase for tissue-specific analysis of gene function in palate and kidney development. Genesis 2007; 45: 618-624.
36. Wagner KD, Wagner N, Guo JK et al. An inducible mouse model for PAX2-dependent glomerular disease: insights into a complex pathogenesis. Curr Biol 2006; 16: 793-800.
37. Miyata T, Nangaku M, Suzuki D et al. A mesangium-predominant gene, megsin, is a new serpin upregulated in IgA nephropathy. J Clin Invest 1998; 102: 828-836.
38. Gawlik A, Quaggin SE. Deciphering the renal code: advances in conditional gene targeting. Physiology (Bethesda) 2004; 19: 245-252.
39. Bianco RA, Keen HL, Lavoie JL et al. Untraditional methods for targeting the kidney in transgenic mice. Am J Physiol Renal Physiol 2003; 285: F1027-F1033.
40. Schnutgen F, Ghyselinck NB. Adopting the good reFLEXes when generating conditional alterations in the mouse genome. Transgenic Res 2007; 16: 405-413.
41. Loonstra A, Vooijs M, Beverloo HB et al. Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells. Proc Natl Acad Sci USA 2001; 98: 9209-9214.
42. Schmidt-Supprian M, Rajewsky K. Vagaries of conditional gene targeting. Nat Immunol 2007; 8: 665-668.
43. Semprini S, Troup TJ, Kotelevtseva N et al. Cryptic loxP sites in mammalian genomes: genome-wide distribution and relevance for the efficiency of BAC/PAC recombineering techniques. Nucleic Acids Res 2007; 35: 1402-1410.
44. Sadowski PD. The Flp recombinase of the 2-microns plasmid of Saccharomyces cerevisiae. Prog Nucleic Acid Res Mol Biol 1995; 51: 53-91.
45. Meyers EN, Lewandoski M, Martin GR. An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination. Nat Genet 1998; 18: 136-141.
46. Raymond CS, Soriano P. High-efficiency FLP and PhiC31 site-specific recombination in mammalian cells. PLoS ONE 2007; 2: e162.
47. Dymecki SM. Flp recombinase promotes site-specific DNA recombination in embryonic stem cells and transgenic mice. Proc Natl Acad Sci USA 1996; 93: 6191-6196.
48. Thorpe HM, Smith MC. In vitro site-specific integration of bacteriophage DNA catalyzed by a recombinase of the resolvase/invertase family. Proc Natl Acad Sci USA 1998; 95: 5505-5510.
49. Bertoni C, Jarrahian S, Wheeler TM et al. Enhancement of plasmid-mediated gene therapy for muscular dystrophy by directed plasmid integration. Proc Natl Acad Sci USA 2006; 103: 419-424.
50. Olivares EC, Hollis RP, Chalberg TW et al. Site-specific genomic integration produces therapeutic Factor IX levels in mice. Nat Biotechnol 2002; 20: 1124-1128.
51. Hathaway HJ, Shur BD. Mammary gland morphogenesis is inhibited in transgenic mice that overexpress cell surface beta1,4-galactosyltransferase. Development 1996; 122: 2859-2872.
52. Campbell SJ, Carlotti F, Hall PA et al. Regulation of the CYP1A1 promoter in transgenic mice: an exquisitely sensitive on-off system for cell specific gene regulation. J Cell Sci 1996; 109(Pt 11): 2619-2625.
53. Cronin CA, Gluba W, Scrable H. The lac operator-repressor system is functional in the mouse. Genes Dev 2001; 15: 1506-1517.
54. Schneider A, Guan Y, Zhang Y et al. Generation of a conditional allele of the mouse prostaglandin EP4 receptor. Genesis 2004; 40: 7-14.
55. Schneider A, Zhang Y, Guan Y et al. Differential, inducible gene targeting in renal epithelia, vascular endothelium, and viscera of Mx1Cre mice. Am J Physiol Renal Physiol 2003; 284: F411-F417.
56. Saez E, Nelson MC, Eshelman B et al. Identification of ligands and coligands for the ecdysone-regulated gene switch. Proc Natl Acad Sci USA 2000; 97: 14512-14517.
57. Bockamp E, Maringer M, Spangenberg C et al. Of mice and models: improved animal models for biomedical research. Physiol Genomics 2002; 11: 115-132.
58. Kellendonk C, Tronche F, Casanova E et al. Inducible site-specific recombination in the brain. J Mol Biol 1999; 285: 175-182.
59. Lantinga-van Leeuwen IS, Leonhard WN, van der Wal A et al. Kidney-specific inactivation of the Pkd1 gene induces rapid cyst formation in developing kidneys and a slow onset of disease in adult mice. Hum Mol Genet 2007; 16: 3188-3196.
60. Shigehara T, Zaragoza C, Kitiyakara C et al. Inducible podocyte-specific gene expression in transgenic mice. J Am Soc Nephrol 2003; 14: 1998-2003.
61. Wen F, Cecena G, Munoz-Ritchie V et al. Expression of conditional cre recombinase in epithelial tissues of transgenic mice. Genesis 2003; 35: 100-106.
62. Yang B, Zhao D, Qian L et al. Mouse model of inducible nephrogenic diabetes insipidus produced by floxed aquaporin-2 gene deletion. Am J Physiol Renal Physiol 2006; 291: F465-F472.
63. Bugeon L, Danou A, Carpentier D et al. Inducible gene silencing in podocytes: a new tool for studying glomerular function. J Am Soc Nephrol 2003; 14: 786-791.
64. Boyle S, Misfeldt A, Chandler KJ et al. Fate mapping using Cited1-CreER(T2) mice demonstrates that the cap mesenchyme contains self-renewing progenitor cells and gives rise exclusively to nephronic epithelia. Dev Biol 2008; 313: 234-245.
65. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA 1992; 89: 5547-5551.
66. Gossen M, Freundlieb S, Bender G et al. Transcriptional activation by tetracyclines in mammalian cells. Science 1995; 268: 1766-1769.
67. Sun Y, Chen X, Xiao D. Tetracycline-inducible expression systems: new strategies and practices in the transgenic mouse modeling. Acta Biochim Biophys Sin (Shanghai) 2007; 39: 235-246.
68. Barde I, Zanta-Boussif MA, Paisant S et al. Efficient control of gene expression in the hematopoietic system using a single Tet-on inducible lentiviral vector. Mol Ther 2006; 13: 382-390.
69. Feil R, Brocard J, Mascrez B et al. Ligand-activated site-specific recombination in mice. Proc Natl Acad Sci USA 1996; 93: 10887-10890.
70. Indra AK, Warot X, Brocard J et al. Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases. Nucleic Acids Res 1999; 27: 4324-4327.
71. Sohal DS, Nghiem M, Crackower MA et al. Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein. Circ Res 2001; 89: 20-25.
72. Fire A, Xu S, Montgomery MK et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998; 391: 806-811.
73. Elbashir SM, Harborth J, Lendeckel W et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001; 411: 494-498.
74. Hamar P, Song E, Kokeny G et al. Small interfering RNA targeting Fas protects mice against renal ischemia-reperfusion injury. Proc Natl Acad Sci USA 2004; 101: 14883-14888.
75. Zheng X, Feng B, Chen G et al. Preventing renal ischemia-reperfusion injury using small interfering RNA by targeting complement 3 gene. Am J Transplant 2006; 6: 2099-2108.
76. Zheng X, Zhang X, Sun H et al. Protection of renal ischemia injury using combination gene silencing of complement 3 and caspase 3 genes. Transplantation 2006; 82: 1781-1786.
77. Xia Z, Abe K, Furusu A et al. Suppression of renal tubulointerstitial fibrosis by small interfering RNA targeting heat shock protein 47. Am J Nephrol 2008; 28: 34-46.
78. Takabatake Y, Isaka Y, Mizui M et al. Exploring RNA interference as a therapeutic strategy for renal disease. Gene Ther 2005; 12: 965-973.
79. Carrington JC, Ambros V. Role of microRNAs in plant and animal development. Science 2003; 301: 336-338.
80. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002; 296: 550-553.
81. Dann CT. New technology for an old favorite: lentiviral transgenesis and RNAi in rats. Transgenic Res 2007; 16: 571-580.
82. Wang X, Skelley L, Cade R et al. AAV delivery of mineralocorticoid receptor shRNA prevents progression of cold-induced hypertension and attenuates renal damage. Gene Ther 2006; 13: 1097-1103.
83. Gao X, Zhang P. Transgenic RNA interference in mice. Physiology (Bethesda) 2007; 22: 161-166.
84. Silva JM, Li MZ, Chang K et al. Second-generation shRNA libraries covering the mouse and human genomes. Nat Genet 2005; 37: 1281-1288.
85. Kumar LD, Clarke AR. Gene manipulation through the use of small interfering RNA (siRNA): from in vitro to in vivo applications. Adv Drug Deliv Rev 2007; 59: 87-100.
86. Xia H, Mao Q, Paulson HL et al. siRNA-mediated gene silencing in vitro and in vivo. Nat Biotechnol 2002; 20: 1006-1010.
87. Kuhn R, Streif S, Wurst W. RNA interference in mice. Handb Exp Pharmacol 2007; 178: 149-176.
88. Ventura A, Meissner A, Dillon CP et al. Cre-lox-regulated conditional RNA interference from transgenes. Proc Natl Acad Sci USA 2004; 101: 10380-10385.
89. Stegmeier F, Hu G, Rickles RJ et al. A lentiviral microRNA-based system for single-copy polymerase II-regulated RNA interference in mammalian cells. Proc Natl Acad Sci USA 2005; 102: 13212-13217.
90. Szulc J, Wiznerowicz M, Sauvain MO et al. A versatile tool for conditional gene expression and knockdown. Nat Methods 2006; 3: 109-116.
91. Durai S, Mani M, Kandavelou K et al. Zinc finger nucleases: custom-designed molecular scissors for genome engineering of plant and mammalian cells. Nucleic Acids Res 2005; 33: 5978-5990.
92. Moehle EA, Rock JM, Lee YL et al. Targeted gene addition into a specified location in the human genome using designed zinc finger nucleases. Proc Natl Acad Sci USA 2007; 104: 3055-3060.